Premium
Preparation of Cryoprecipitated Factor VIII Concentrates
Author(s) -
Slichter S. J.,
Counts R. B.,
Henderson R.,
Harker L. A.
Publication year - 1976
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1976.16677060245.x
Subject(s) - cryoprecipitate , centrifugation , chemistry , yield (engineering) , chromatography , fresh frozen plasma , whole blood , medicine , surgery , platelet , biochemistry , immunology , fibrinogen , materials science , metallurgy
Factors affecting the yield of factor VIII in cryoprecipitate have been investigated in the context of a blood component program. Both in vitro and in vivo measurements were used to assess the effects of critical variables on the yield of factor VIII activity. Variables such as anticoagulant, plastic bag, mixing during collection, and platelet contamination had no significant effect on yield of factor VIII activity in cryoprecipitate. Among the most critical factors affecting yield were storage time of whole blood and procedures for freezing, thawing, and reconstitution. The following procedures were found to assure a 60 per cent recovery of factor VIII in cryoprecipitate: 1) processing of whole blood within six hours of collection; 2) use of a technique to freeze plasma within 30 minutes either in a –70 C ethanol bath or –85 C freezer; 3) rapid thawing (1 ½ hour or less) in a 4 C circulating water bath; 4) centrifugation at 4,500 × g for 10 minutes at 4 C followed by draining of the supernatant in a 4 C cold room; 5) storage of the precipitate at –20 C until ready for use; 6) thawing in a 37 C water bath for at least 15 minutes followed by addition of 20 ml of 0.15 M saline for a 20 minute period at room temperature, and gentle mixing before pooling units for transfusion. The recovery of factor VIII in cryoprecipitate appears to be limited to about 65 per cent by its solubility in plasma at 4 C. Therefore, further effort to increase the amount available for treatment should involve improving the supply of plasma for its preparation and decreasing the cost of processing.